{"SPADE_UN_15409": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15409", "Peptide Name": "LTX-328", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "KAQXQKQAW", "Sequence Length": 9, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:FEMX-I (IC50>350 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C44H68N14O11", "Mass": 122200, "PI": 10.81, "Net Charge": 2, "Hydrophobicity": -1.733, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315", "Pubmed ID": "24676901", "Reference": "Cancer Immunol Immunother. 2014 Jun;63(6)601-13.", "Author": "Camilio KA, Berge G, Ravuri CS, Rekdal O, Sveinbjørnsson B.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=24676901"}], "Frequent Amino Acids": "QAK", "Absent Amino Acids": "CDEFGHILMNOPRSTUVY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 3, "Polar Residues": 7, "Positive Residues": 2, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_11547", "Similarity": 1.0, "Sequence": "CKYKAQ"}, {"SPADE_ID": "SPADE_UN_30869", "Similarity": 1.0, "Sequence": "CKYKAQ"}, {"SPADE_ID": "SPADE_N_02663", "Similarity": 0.8, "Sequence": "DLHIPPPDNKINWPQLSGGGGGSPKTGYDININAQQK"}]}}}